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Surface radio-mineralisation mediates chelate-free 
radiolabelling of iron oxide nanoparticles
Heat-induced radiolabelling of iron oxide nanoparticles provides 
a simpler and faster alternative to traditional chelate-based 
radiolabelling strategies. We show that this method operates 
through trace deposition of radio-metal oxides (including 111In2O3 
and 89ZrO2) on iron oxide nanoparticle surfaces, neither changing 
the original magnetic or physical properties of the particle core.
This facilitates assessment of in vivo particle biodistibution 
dynamics using highly-sensitive and quantitative nuclear imaging 
(PET and SPECT) alongside high-resolution magnetic resonance 
imaging (MRI). This technique will aid the development, validation, 
and translation of iron-oxide nano- and micro-particle-based 
therapies.
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Michael J. Powell,c May Zaw-Thin,a Nicolas H. Voelcker,ef Ivan P. Parkin, c
Quentin A. Pankhurst, d Mark F. Lythgoe,a Tammy L. Kalber a
and Joseph C. Bear *b
We introduce the concept of surface radio-mineralisation (SRM) to describe the chelate-free radiolabelling
of iron-oxide and ferrite nanoparticles. We demonstrate the eﬀectiveness of SRM with both 111In and 89Zr
for bare, polymer-matrix multicore, and surface-functionalised magnetite/maghemite nanoparticles; and
for bare Y3Fe5O12 nanoparticles. By analogy with geological mineralisation (the hydrothermal deposition
of metals as minerals in ore bodies or lodes) we demonstrate that the heat-induced and aqueous SRM
process deposits radiometal-oxides onto the nanoparticle or core surfaces, passing through the matrix
or coating if present, without changing the size, structure, or magnetic properties of the nanoparticle or
core. We show in a mouse model followed over 7 days that the SRM is suﬃcient to allow quantitative,
non-invasive, prolonged, whole-body localisation of injected nanoparticles with nuclear imaging.Introduction
The tuneable properties of iron oxide nanoparticles (IONPs),
primarily magnetite, maghemite, or mixtures thereof, and
their capacity for functionalisation suit them for numerous
biomedical applications: hyperthermia therapy for cancer;
drug, cell and gene delivery, and as diagnostic or cell tracking
agents.1–7 The ability of superparamagnetic nanoparticles to
de-phase the MRI-detectable water proton (1H) signal enables
their detection in tissues as hypo-intensities, conrming
delivery and retention with high resolution and sensitivity.
Yet, in practice, identication of IONPs with magnetic reso-
nance imaging (MRI) is oen ambiguous due to endogenous
signal hypo-intensities including the lungs, bone, and gut
(Fig. 1). Particle quantication is also hampered by satura-
tion of signal loss at high concentrations, insuﬃcient sensi-
tivity to low concentrations, and aggregation eﬀects on
relaxivity.8,9ABI), Department of Medicine, University
mail: peter.patrick@ucl.ac.uk
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Chemistry, University College London, 20
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s, Monash University, Parkville, Australia
esearch Organisation (CSIRO), Clayton,
tion (ESI) available. See DOI:
7These limitations have spurred research into conjugation
and chelation chemistry for radiolabelling IONPs, to enable
their detection and quantication with nuclear imaging.2,10,11
Single photon emission computed tomography (SPECT), and
positron emission tomography (PET) detect g-radiation
respectively produced directly or indirectly (aer positron
annihilation) following radioisotope decay. This oﬀers accurate
and sensitive quantication of imaging isotopes across the
body, without endogenous background signals from tissue.
Traditionally, nanoparticle radiolabelling requires surface
functionalisation with organic chelators10 – increasing the
complexity, time and cost of synthesis. A standard method of
radiolabelling IONPs has proven elusive as radiometals diﬀer in
co-ordination numbers and atomic radii, therefore requiring
diﬀerent chelating agents and conjugation strategies.12
Radiochemical doping provides one alternative to the use
of chelators, whereby radiometals such as 64Cu and 111In are
incorporated in the iron oxide core during its synthesis.13,14
This has the advantage of stable radiolabel retention. However
its practicality is reduced by the necessity of synthesising (and
possibly functionalising) particles on-demand before every use
due to the constraints of isotope half-lives. A more user
friendly and clinically-translatable approach would allow last-
minute labelling of oﬀ-the-shelf iron oxide nanoparticles with
the chosen isotope prior to injection. With this in mind, Chen
et al. demonstrated a post-synthesis, chelate-free method for
radiolabelling uncoated iron oxides using radioarsenic (71As,
72As, 74As, 76As),15 which was followed by a similar demon-
stration using 69Ge, also for PET imaging.16 To expand upon
this, Boros et al. labelled the FDA-approved, carbohydrateThis journal is © The Royal Society of Chemistry 2019
Fig. 1 Synthesis of radiolabelled IONPs using radiometal chloride salts (MCln) to form an oxidised radiometal coating allows whole-body non-
invasive quantitative imaging using PET or SPECT, in addition to high-resolution detection using MRI.
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View Article Onlinecoated IONP ferumoxytol (Feraheme®) with a range of more
commonly available radiometal isotopes, including 89Zr and
64Cu for PET and 111In for SPECT.17 Particles were heated in an
aqueous solution with the radiometal chloride ($80 C was
optimal for most metals tested, including Zr, Cu, and In) at
a pH between 7–9. However, despite ongoing interest in this
method,2,7 the nature of the chemical interaction between the
metal isotopes and iron oxide nanoparticles remained
unidentied.18
Here, we address this problem by applying a combination
of energy-dispersive X-ray spectroscopy (EDS), X-ray photo-
electron spectroscopy (XPS), time of ight mass spectrometry
(ToF-SIMS) and room temperature 57Fe Mo¨ssbauer spectros-
copy, to elucidate the mechanistics of heat-induced iron oxide
and ferrite radiolabelling as described by Boros et al. We
establish that it operates primarily through mineralisation of
the radiometal onto the particle surface as a radiometal oxide
(see Fig. 1). We show that this surface radiomineralisation
(SRM) has no eﬀect on the structural and chemical properties
of commercially available maghemite and magnetite/
maghemite-based IONPs, and that as the key magnetic
properties of the particles remain unchanged, their utility for
MRI and other biomedical applications is retained. Finally,
we demonstrate tracking of 111In radiolabelled IONPs using
whole-body, non-invasive SPECT imaging, thereby illustrating
key advantages over the use of MRI alone.Table 1 Radiochemical yield (RCY) independently measured with thin
between the two measurements across the maghemite and (nominally) m
showed negligible activity retention following either TLC or attempted m
Nominal chemical
composition
Nominal
particle
diameter Supplier Matrix
111In RC
TLC,
n ¼ 11
N/A control — — — 0.7 (0.
Maghemite (g-Fe2O3) 20–40 nm Alfa Aesar Bare 79.1 (4.
Magnetite (Fe3O4) 50–100 nm Sigma Aldrich Bare 85.2 (3.
Y3Fe5O12 <100 nm Sigma Aldrich Bare 88.2 (3.
a Magnetic separation of Y3Fe5O12 was not completely successful as indic
This journal is © The Royal Society of Chemistry 2019Results
We initially investigated the ability of the reported method17 to
induce radiolabelling of commercially-available nanoparticles
representing the two magnetic materials most commonly used
in biomedical applications: maghemite (g-Fe2O3), and
magnetite (Fe3O4).4 As we have shown previously, commercially
available magnetite is typically a magnetite/maghemite
mixture despite being labelled as >98% magnetite, which we
conrmed here using a model-independent tting of the 57Fe
Mo¨ssbauer spectrum of the “magnetite” sample, as per Fock
and Bogart et al.,19 which indicated a mixture comprising
z63 wt% magnetite and 37 wt% maghemite. The maghemite
and the magnetite/maghemite particles were then labelled via
heating to 90 C at pH 9 in the presence of 100 to 200 kBq of
either 111In or 89Zr, for 90 min (Table 1). This resulted in 79% to
94% retention of the radioactivity on the particles; assessed by
either thin layer chromatography (TLC) or magnetic
separation.
The radiolabelling eﬃciency was slightly higher using 89Zr
than with 111In, consistent with the previous report on fer-
umoxytol.17 Labelling was repeated using non-radioactive
(natural abundance) metal isotopes of InCl3 and ZrCl4 (10
mmol metal chloride additive per 100 mg of IONPs). Metal
additives were successfully incorporated into IONPs as assessed
by inductively coupled plasma mass spectrometry, ICP-MS (17layer chromatography (TLC) and magnetic separation. Correlation
agnetite samples was R2 ¼ 0.93. Reactions without magnetic particles
agnetic separation
Y (%) 89Zr RCY (%)
(SEM)
Magnetic separation,
n ¼ 4 (SEM)
TLC,
n ¼ 10 (SEM)
Magnetic separation,
n ¼ 4 (SEM)
5) 0.4 (0.2) 2.46 (2.9) 0.4 (0.2)
9) 79.3 (6.8) 94.2 (0.7) 94.7 (0.4)
1) 78.6 (6.4) 94.9 (1.1) 94.2 (0.7)
7) 66.6 (3.5)a 91.9 (1.3) 71.9 (3.5)a
ated by visual inspection.
Chem. Sci., 2019, 10, 2592–2597 | 2593
Fig. 2 Characterisation of maghemite (Alfa Aesar) g-Fe2O3 following
111In labelling. High resolution TEM images (A–C), show no discernible
change in lattice structure from bulk iron oxide. (C) Lattice d-spacing of 2.87 A˚ assigned as the (220) plane of maghemite. (D) SQUID
measurement of maghemite (g-Fe2O3) before and after modiﬁcation shows comparable magnetisation curves. (E) Mo¨ssbauer spectra acquired
for maghemite (Fe2O3) particles before and after heat induced labelling with non-radioactive In and Zr additives. No change in the proportion of
Fe atoms in amaghemite environment was seen following the labelling reaction. (F) EDS spectrum shows the presence of added In. (G) ToF-SIMS
demonstrates a sharp decrease in In concentration with increasing sputter time, indicating its surface bound nature.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
9 
Ja
nu
ar
y 
20
19
. D
ow
nl
oa
de
d 
on
 3
/1
9/
20
19
 1
2:
19
:0
3 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineto 51%), giving the same trend of higher labelling eﬃciencies
for Zr compared to In (Table S1†). To show the broader appli-
cability of this process with alternative iron oxides, yttrium iron
oxide nanoparticles (Y3Fe5O12) were also successfully radio-
labelled (Table 1).
In order to establish the eﬀect of In and Zr labelling on the
physical properties of magnetite/maghemite and Y3Fe5O12
nanoparticles, we have used both transmission electron
microscopy (TEM) and powder X-ray diﬀraction (pXRD) and
observed no discernible change in the physical structure of the
nanoparticles following the labelling treatment (Fig. 2). TEM
imaging clearly showed that there was no change in the physical
structure of the nanoparticles followed the labelling treatment
(Fig. 2). The core sizes of each sample displayed the familiar
log-normal size distribution, which remained unchanged
regardless of reaction conditions. Indeed, due to the highly
polydisperse nature of the nanoparticles (as seen by the large
standard deviation), any change in size was impossible to see:
35.3  20.5 nm for the maghemite, 19.1  15.8 nm for the
Y3Fe5O12 and 116.6  79.0 nm for the magnetite/maghemite.
High resolution TEM analysis (Fig. 2A–C and S14–S22†) clearly
shows the lack of core/shell structure and no change in the
lattice planes of the nanoparticles, consistent with pXRD
observations (Fig. S1–S4†). The inability to detect either In or Zr
via pXRD suggests an amorphous and non-crystalline incorpo-
ration, as would be expected based on the relatively low reaction
temperature. The presence of small amounts of In and Zr within
the samples was conrmed with energy dispersive X-ray spec-
troscopy (EDS) (Fig. 2F and S14–S22†).
To quantify any change in composition following heating
and radiolabelling, the maghemite and magnetite/maghemite
particles were analysed with room temperature 57Fe Mo¨ssbauer
spectroscopy19 before and aer In and Zr labelling (Fig. S23†).2594 | Chem. Sci., 2019, 10, 2592–2597For the labelled maghemite samples there was no change in the
measured spectra for all of the treated samples; we conrmed
this quantitatively by observing no change to the value of the
a parameter (the numerical proportion of Fe atoms in the
magnetite environment), with a ¼ 0  0.04, consistent with
pure maghemite.19,20 Similarly, for the treated Sigma Aldrich
“magnetite” samples there was no change to the spectra, with
the best t isomer shi indicating a ¼ 0.52  0.02, corre-
sponding to a magnetite content of ca. 56 wt%. Such observa-
tions strongly suggest that there is no incorporation of either
the In or Zr within the sub-lattice structures of the iron oxide,
indicating a surface location.
We conrmed this using X-ray photoelectron spectroscopy
(XPS; a surface (<10 nm) sensitive technique) to probe the
oxidation state and quantities of the In and Zr additives
(Fig. S5–S13†). All samples showed the presence and absence of
the In and/or Zr additives where appropriate. Fe environments
were largely unchanged aer In/Zr treatment, with only 0.1 eV
variation across the three samples in Fe 2p scans, in good
agreement with the Mo¨ssbauer spectra. The Fe 2p3/2 values of
710.6 (AA maghemite), 710.7 (SA magnetite), and 710.3 eV
(Y3Fe5O12) are indicative of g-Fe2O3 (710.6, 710.7 eV) and
Y3Fe5O12 (710.3 eV) respectively.21,22 There was also little varia-
tion within the Y3Fe5O12 samples, with a single environment,
and a variation in the Y 3d5/2 range of 157.0–157.3 eV displayed,
similar to that observed in Y2O3.23
Both the In and Zr additives were clearly seen in single
chemical environments, for all treated samples. Scans of In 3d
showed In with a 3+ oxidation state, assigned as In2O3 at
444.3 eV and Zr 3d scans showed a Zr 3d5/2 peak at 182.0 eV
assigned as ZrO2, with Zr in the 4+ oxidation state. The high
oxidation states of the additive elements and the absence of any
observable change or indeed new chemical environments inThis journal is © The Royal Society of Chemistry 2019
Table 2 Radiochemical yield of labelled particles following heating with 111In or 89Zr at 90 C for 90 min. Labelling eﬃciency was assessed using
TLC and independently with magnetic separation. Magnetic separation of 50 nm FluidMag was unsuccessful
Particle type
Nominal particle
diameter Matrix
111In % RCY 89Zr % RCY
TLC (SEM),
n ¼ 11
Magnetic separation
(SEM), n ¼ 4
TLC (SEM),
n ¼ 10
Magnetic separation
(SEM), n ¼ 8
FluidMag 50 nm Citrate 68.5 (3.1) — 86.3 (1.8) —
FluidMag 100 nm Citrate 70.3 (3.8) 81.1 (7.7) 87.9 (2.2) 83.4 (5.9)
FluidMag 200 nm Citrate 69.1 (3.5) 84.9 (6.7) 93.3 (0.9) 94.8 (0.5)
Biomag Maxi 3–12 mm Carboxyl functionalised
alkoxysilane
71.4 (3.1) 86.1 (6.0) 82.8 (1.6) 93.3 (1.5)
SiMag 500 nm Silanol 80.4 (3.1) 83.7 (1.5) 71.5 (2.8) 64.3 (5.0)
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View Article Onlineeither the O 1s or Fe 2p high resolution scans, leads us to
conclude that the additives are surface bound and not fully
integrated (doped) into the iron oxide structure, which is sup-
ported by pXRD and Mo¨ssbauer spectroscopy (Fig. S1–S4†).
Based on the amount of In detected in the samples by ICP-MS,
this gives a ratio of 1 In atom for every 3 to 20 surface Fe atoms
per nanoparticle for the magnetite/maghemite and maghemite
particles respectively – consistent with the absence of shell
detection with TEM.
The surface location of additives was further established
with time of ight-secondary ion mass spectroscopy (ToF-
SIMS), which was used to remove atomic monolayers of
metal ions from the surface of the IONPs. Fig. 2G presents the
ToF-SIMS depth prole for the In doped maghemite (g-Fe2O3-
In), in which the In concentration shows a sharp drop with
etching time. The slight increase in iron concentration can be
attributed to its dominance within the core of the NPs, which
becomes more clear on removal of the In. These measure-
ments were complemented by the ToF-SIMS depth prole
measurements of the Y3Fe5O12 NPs (Fig. S28, ESI†). From this,Fig. 3 MRI pre (A) and post (B) injection of the 111In-FluidMagCT, or (C) po
CT at 3 h, 2 and 7 d post-injection conﬁrms presence of labelled iron o
responding axial slices show co-localisation of the radiolabelled IONPs
This journal is © The Royal Society of Chemistry 2019we propose that the In atoms are surface bound, consistent
with the mild nature of the radiolabelling reaction and its
negligible eﬀects on the structural (by TEM) and physical (vide
infra) properties of the particles. ToF-SIMS of the Zr-doped
maghemite and Y3Fe5O12 NPs was complicated by the ion-
isation eﬃciency of Zr and the overlapping mass with the Y
fragment. Furthermore, ToF-SIMS is more surface sensitive
than XPS; which means the ion beam penetration was
considerably lower than that of the XPS measurements
(sampling depth is considerably less).24 Despite this, Zr was
successfully detected using XPS (Fig. S5–S13†).
Following the demonstration of In and Zr surface minerali-
sation using this method, we next sought to demonstrate wider
utility with a range of maghemite and magnetite-based nano-
and microparticles coated for biomedical application. A small
selection of commercially-available magnetic nanoparticles was
chosen for variation in size and coating, and labelled with either
111In or 89Zr according to the protocol described above. As with
the uncoated maghemite and magnetite/maghemite particles
(Table 1), this resulted in eﬃcient radiochemical yields (RCYs)st-FluidMagCT (control). (D) Maximum intensity projection 111In SPECT-
xides in the liver, lung, kidneys, and spleen of C57BL/6 mice. (E) Cor-
and the liver.
Chem. Sci., 2019, 10, 2592–2597 | 2595
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View Article Onlinebetween 68 and 95% as assessed with TLC and magnetic
separation (Table 2).
To monitor the eﬀects of the radiolabelling procedure on the
magnetic properties of a selection of these particles, super-
conducting quantum interference device (SQUID) measure-
ments were taken aer labelling with non-radioactive ZrCl4 and
InCl3 additives at a ratio 10 mmol per 100 mg particle (see Table
S2, Fig. S24–S27†). For each particle type except the Y3Fe5O12
(which showed altered coercivity but not saturation magnet-
isation or remanence), magnetisation curves were comparable
between unmodied particles and those labelled with Zr and In
(Fig. 2D).
We lastly demonstrate that particles labelled with this
method are suitable for in vivo imaging with MRI and SPECT.
FluidMag CT was chosen as a representative particle for
biomedical application as it is commercially available and has
previously been evaluated for stem cell labelling and hyper-
thermia.25,26 MRI was done prior to and 2.5 h following intra-
venous injection to monitor the distribution of the labelled
particles in wild type mice (C57BL/6 strain). Signal hypo-
intensity was present in the lungs only pre-injection (Fig. 3A),
and post-injection in lungs, liver, and kidneys (Fig. 3B) –
consistent with previous reports of excretory organ nanoparticle
uptake.27 An equivalent dose of unmodied stock particles were
injected into a separate animal, and gave comparable distri-
bution of MRI contrast as the radiolabelled particles, predom-
inantly in the liver (Fig. 3B and C).
SPECT-CT imaging at 3 h, 2 d, and 7 d post injection
conrmed the location of the 111In-labelled IONPs within the
liver and kidneys (see Fig. 3), showing additional retention
within the lungs which was diﬃcult to identify on the MR
images due to endogenous contrast. At 2 and 7 d SPECT-CT
showed a clearing of the particles from the lungs – again not
detectable using MRI. Quantication of total activity with
SPECT ROI analysis showed the majority of activity (54.5%)
retained in the liver aer 7 days.
Conclusion
In conclusion, using a combination of TEM, 57Fe Mo¨ssbauer
spectroscopy, XPS, ToF-SIMS and SQUID we have demon-
strated that heat-mediated chelate-free radiolabelling method
as described by Boros et al.17 operates by mineralisation of the
radiometal (111In or 89Zr) as an oxide on the surface of the
IONP that does not alter the magnetic and physical properties
of the particle core. Further, we have shown that this surface
radio-mineralisation (SRM) is compatible with a range of
nano- and microscale iron oxide particles (maghemite and
magnetite/maghemite), as well as yttrium iron oxide
(Y3Fe5O12) as a representative non-typical iron oxide. ToF-SIMS
analysis shows radiometal incorporation is limited to the
surface of the particles, consistent with the lack of change in
the magnetite–maghemite content of the starting material.
With the exception of a slight eﬀect on the Y3Fe5O12 particles
this was conrmed by means of SQUID analysis, which showed
that their original magnetisation curves were retained
following labelling.2596 | Chem. Sci., 2019, 10, 2592–2597This report aﬀords a better understanding of the heat-
induced chelate-free radiolabelling method. We anticipate
that this will encourage its use in investigating the bio-
distribution of the IONP-based biomedical therapeutics and
diagnostics, thus combining the quantitative high-sensitivity of
PET/SPECT imaging with the high-resolution detail of MRI.
Experimental section
Detailed descriptions of the instrumentation, materials and
experimental protocols can be found in the ESI.†
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